stockrow
Saturday 31 October 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
19.74
0.13
+0.66%
Follow SBRA
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
25.19 | 29.14 | 30.05 | 75.04 |
P/S ratio |
6.00 | 5.90 | 5.96 | 5.73 | |
P/FCF ratio |
60.24 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
44.73 | 52.28 | 49.29 | 57.35 | |
P/B ratio |
1.58 | 1.62 | 1.74 | 1.79 | |
Price to Tangible BV |
1.62 | 1.66 | 1.78 | 1.84 | |
EV/Sales |
9.20 | 9.06 | 9.09 | 8.50 | |
EV/EBITDA |
15.66 | 15.83 | 16.30 | 19.96 | |
EV/Operating CF |
20.09 | 20.14 | 20.15 | 19.67 | |
EV/FCF |
92.36 | (122.74) | (56.23) | (26.37) | |
Quick Ratio |
1.67 | 0.65 | 1.05 | 2.07 | |
Current Ratio |
5.19 | 4.29 | 4.72 | 3.07 | |
Net Debt/EBITDA |
22.60 | 21.25 | 21.00 | 98.14 | |
Debt/Assets |
46.56% | 46.04% | 47.67% | 47.64% | |
Debt/Equity |
0.92 | 0.90 | 0.96 | 0.95 | |
Asset Turnover |
0.14 | 0.14 | 0.15 | 0.16 | |
Operating CF/Net income |
4.44 | 3.21 | 2.41 | (3.41) | |
Capex/Depreciation |
(4.29) | (2.40) | (2.03) | (3.72) | |
Interest Coverage |
1.97 | 2.21 | 2.39 | (1.08) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.61% | 7.51% | 6.70% | 7.13% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.02 | |
Share Based Compensation of Revenue |
1.51% | 1.45% | 1.40% | 1.73% | |
Graham Net Nets |
(0.47) | (0.47) | (0.46) | (0.49) | |
Graham Number |
14.01 | 13.08 | 12.62 | 7.99 | |
Earnings Yield |
3.97% | 3.43% | 3.33% | 1.33% | |
Free Cash Flow Yield |
1.66% | (1.25%) | (2.71%) | (5.63%) | |
Revenue per Share |
0.79 | 0.88 | 0.88 | 0.94 | |
Operating CF per Share |
0.42 | 0.36 | 0.39 | 0.34 | |
Capex per Share |
(0.87) | (0.51) | (0.43) | (0.83) | |
Free Cash Flow per Share |
(0.45) | (0.15) | (0.04) | (0.49) | |
Cash per Share |
0.87 | 0.32 | 0.49 | 0.94 | |
Shareholders Equity per Share |
11.78 | 11.70 | 11.06 | 10.91 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.78 | 11.70 | 11.06 | 10.91 | |
Free Cash Flow |
(107.99) | (35.73) | (9.59) | (123.92) | |
Working Capital |
520.00 | 392.91 | 438.41 | 238.47 | |
Capital Expenditures |
(207.95) | (123.16) | (107.95) | (209.74) | |
Net Current Asset Value |
(2,093.78) | (2,157.37) | (2,246.92) | (2,406.75) | |
EV/EBIT |
26.38 | 27.37 | 28.77 | 46.63 | |
Capex to Sales |
1.09 | 0.58 | 0.49 | 0.89 | |
Price to Operating Income |
17.20 | 17.82 | 18.88 | 31.40 | |
| Other line items | |||||
Average Payables |
123.42 | 118.61 | 115.01 | 114.01 | |
Average Assets |
5,465.45 | 5,398.54 | 5,412.19 | 5,420.30 | |
Average Common Equity |
2,785.90 | 2,782.54 | 2,745.07 | 2,731.96 |
Columns are period end dates